Amphastar Pharmaceuticals, Inc. (AMPH): Price and Financial Metrics

Amphastar Pharmaceuticals, Inc. (AMPH): $37.57

0.66 (+1.79%)

POWR Rating

Component Grades














  • AMPH scores best on the Sentiment dimension, with a Sentiment rank ahead of 85.95% of US stocks.
  • AMPH's strongest trending metric is Stability; it's been moving up over the last 179 days.
  • AMPH ranks lowest in Momentum; there it ranks in the 6th percentile.

AMPH Stock Summary

  • Of note is the ratio of AMPHASTAR PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; merely 24.25% of US stocks have a lower such ratio.
  • AMPH's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 24.02% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, AMPHASTAR PHARMACEUTICALS INC is reporting a growth rate of 39.55%; that's higher than 73.84% of US stocks.
  • Stocks that are quantitatively similar to AMPH, based on their financial statements, market capitalization, and price volatility, are NVMI, CPTN, ACMR, ALRM, and MTSI.
  • Visit AMPH's SEC page to see the company's official filings. To visit the company's web site, go to

AMPH Valuation Summary

  • In comparison to the median Healthcare stock, AMPH's price/sales ratio is 25.53% lower, now standing at 3.5.
  • AMPH's price/sales ratio has moved up 1.8 over the prior 106 months.

Below are key valuation metrics over time for AMPH.

Stock Date P/S P/B P/E EV/EBIT
AMPH 2023-03-17 3.5 3.3 19.0 14.4
AMPH 2023-03-16 3.6 3.4 19.7 15.0
AMPH 2023-03-15 3.5 3.3 19.3 14.7
AMPH 2023-03-14 3.6 3.4 19.5 14.8
AMPH 2023-03-13 3.4 3.2 18.7 14.2
AMPH 2023-03-10 3.4 3.2 18.7 14.2

AMPH Growth Metrics

    The 3 year net cashflow from operations growth rate now stands at 380.28%.
  • Its 5 year cash and equivalents growth rate is now at -26.13%.
  • The 5 year price growth rate now stands at 26.94%.
Over the past 67 months, AMPH's revenue has gone up $232,382,000.

The table below shows AMPH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 484.851 114.396 77.233
2022-06-30 476.92 96.59 90.907
2022-03-31 455.116 125.934 81.328
2021-12-31 437.768 97.994 62.116
2021-09-30 412.802 74.446 36.083
2021-06-30 384.035 80.684 10.454

AMPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMPH has a Quality Grade of C, ranking ahead of 66.19% of graded US stocks.
  • AMPH's asset turnover comes in at 0.601 -- ranking 59th of 680 Pharmaceutical Products stocks.
  • VTVT, MTEX, and BBI are the stocks whose asset turnover ratios are most correlated with AMPH.

The table below shows AMPH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.601 0.431 0.042
2021-03-31 0.591 0.411 0.012
2020-12-31 0.579 0.410 0.012
2020-09-30 0.568 0.415 0.026
2020-06-30 0.570 0.415 0.017
2020-03-31 0.558 0.421 0.160

AMPH Price Target

For more insight on analysts targets of AMPH, see our AMPH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $22.75 Average Broker Recommendation 1.75 (Moderate Buy)

AMPH Stock Price Chart Interactive Chart >

Price chart for AMPH

AMPH Price/Volume Stats

Current price $37.57 52-week high $44.46
Prev. close $36.91 52-week low $26.76
Day low $36.45 Volume 205,600
Day high $37.60 Avg. volume 272,347
50-day MA $32.93 Dividend yield N/A
200-day MA $31.40 Market Cap 1.80B

Amphastar Pharmaceuticals, Inc. (AMPH) Company Bio

Amphastar Pharmaceuticals focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable and inhalation products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company was founded in 1996 and is based in Rancho Cucamonga, California.

AMPH Latest News Stream

Event/Time News Detail
Loading, please wait...

AMPH Latest Social Stream

Loading social stream, please wait...

View Full AMPH Social Stream

Latest AMPH News From Around the Web

Below are the latest news stories about AMPHASTAR PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMPH as an investment opportunity.

The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks

The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.

Yahoo | March 24, 2023

Is Addus HomeCare (ADUS) Stock Outpacing Its Medical Peers This Year?

Here is how Addus HomeCare (ADUS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Yahoo | March 24, 2023

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is favoured by institutional owners who hold 62% of the company

Key Insights Significantly high institutional ownership implies Amphastar Pharmaceuticals' stock price is sensitive to...

Yahoo | March 18, 2023

Amphastar Pharmaceuticals (AMPH)'s Technical Outlook is Bright After Key Golden Cross

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Yahoo | March 13, 2023

2 Stocks to Buy Now After Powell Flips the Narrative... Again

Expectations for the next FOMC meeting have seen odds of a 50bps rate hike go from extremely unlikely to highly likely

Yahoo | March 9, 2023

Read More 'AMPH' Stories Here

AMPH Price Returns

1-mo 15.46%
3-mo N/A
6-mo 32.43%
1-year 3.10%
3-year 161.27%
5-year 103.41%
YTD 34.08%
2022 20.31%
2021 15.81%
2020 4.25%
2019 -3.07%
2018 3.43%

Continue Researching AMPH

Want to see what other sources are saying about Amphastar Pharmaceuticals Inc's financials and stock price? Try the links below:

Amphastar Pharmaceuticals Inc (AMPH) Stock Price | Nasdaq
Amphastar Pharmaceuticals Inc (AMPH) Stock Quote, History and News - Yahoo Finance
Amphastar Pharmaceuticals Inc (AMPH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9015 seconds.